These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3724295)

  • 1. Participation of angiotensin II in learning and memory. II. Interactions of angiotensin II with dopaminergic drugs.
    Yonkov DI; Georgiev VP; Opitz MJ
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):203-6. PubMed ID: 3724295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of angiotensin II in learning and memory. I. Interaction of angiotensin II with saralasin.
    Georgiev V; Yonkov D
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):415-8. PubMed ID: 4079591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic influence on the effects of angiotensin II in behavioural reactions.
    Georgiev V; György L; Yonkov D; Getova D; Markovska V; Petkova B
    Physiol Bohemoslov; 1985; 34 Suppl():45-8. PubMed ID: 3014581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of angiotensin II in learning and memory. III. Interactions of angiotensin II with GABAergic drugs.
    Yonkov D; Georgiev V; Kambourova T; Opitz M
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):205-8. PubMed ID: 3600095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of brain dopaminergic systems in the memory effects of central stimulants.
    Yonkov DI
    Methods Find Exp Clin Pharmacol; 1984 May; 6(5):235-9. PubMed ID: 6147449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
    Georgiev V
    Pol J Pharmacol Pharm; 1990; 42(6):553-62. PubMed ID: 1983291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory impairment induced by combined disturbance of noradrenergic and dopaminergic neurotransmissions: effects of nootropic drugs.
    Lazarova-Bakarova MB; Petkova BP; Todorov IK; Petkov VD
    Acta Physiol Pharmacol Bulg; 1991; 17(1):29-34. PubMed ID: 1667717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of apomorphine and haloperidol on memory consolidation in the day-old chick.
    Hale MW; Crowe SF
    Behav Neurosci; 2001 Apr; 115(2):376-83. PubMed ID: 11345962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence for the GABAergic influence on memory. Interaction of GABAergic transmission with angiotensin II on memory processes.
    Yonkov D; Georgiev V; Kambourova T
    Methods Find Exp Clin Pharmacol; 1989 Oct; 11(10):603-6. PubMed ID: 2555635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of the angiotensin II effects on the exploratory behavior of rats in open field. I. Interaction of angiotensin II with saralasin and catecholaminergic drugs.
    Georgiev V; Getova D; Opitz M
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):297-301. PubMed ID: 3613758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory effects of GABA-ergic antagonists in rats trained with two-way active avoidance tasks.
    Yonkov DI; Georgiev VP
    Acta Physiol Pharmacol Bulg; 1985; 11(2):44-9. PubMed ID: 2996297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term consequences of early experience on adult avoidance learning in female rats: role of the dopaminergic system.
    Schäble S; Poeggel G; Braun K; Gruss M
    Neurobiol Learn Mem; 2007 Jan; 87(1):109-22. PubMed ID: 16938473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II disrupts inhibitory avoidance memory retrieval.
    Bonini JS; Bevilaqua LR; Zinn CG; Kerr DS; Medina JH; Izquierdo I; Cammarota M
    Horm Behav; 2006 Aug; 50(2):308-13. PubMed ID: 16697382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between angiotensin II and baclofen in shuttle-box and passive avoidance performance.
    Georgiev VP; Yonkov DI; Kambourova TS
    Neuropeptides; 1988 Oct; 12(3):155-8. PubMed ID: 3241628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the cerebral dopaminergic neurotransmission for the individual differences in learning and memory (experiments on rats).
    Kehayov R; Markovska V; Kamburova T
    Acta Physiol Pharmacol Bulg; 1989; 15(1):76-82. PubMed ID: 2549763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+)-UH 232, a partial agonist of the D3 dopamine receptors, attenuates cognitive effects of angiotensin IV and des-Phe(6)-angiotensin IV in rats.
    Braszko JJ
    Eur Neuropsychopharmacol; 2010 Apr; 20(4):218-25. PubMed ID: 20042318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal CRF, NE, and NMDA system interactions in memory processing in the rat.
    Lee EH; Lee CP; Wang HI; Lin WR
    Synapse; 1993 Jun; 14(2):144-53. PubMed ID: 7687386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel antagonists enhance retention of passive avoidance and maze learning in mice.
    Quartermain D; deSoria VG; Kwan A
    Neurobiol Learn Mem; 2001 Jan; 75(1):77-90. PubMed ID: 11124048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of meclofenoxate on learning and memory--dependence on the experimental conditions.
    Mosharrof AH; Yonkov D; Petkov VD; Kambourova T; Todorov I; Alova L
    Acta Physiol Pharmacol Bulg; 1986; 12(3):7-14. PubMed ID: 3101398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.